This inventor holds 4 USPTO granted patents. Top assignees: Columbia University, Kabi Pharmacia Ab. Active years: 1986-1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1986-1996
Title: Laszlo Z Bito: Innovator in Ocular Therapeutics
Introduction
Laszlo Z Bito is a prominent inventor based in New York, NY (US), known for his significant contributions to the field of ocular therapeutics. He holds a total of 4 patents, showcasing his innovative approach to addressing ocular hypertension and glaucoma.
Latest Patents
Among his latest patents are groundbreaking inventions related to thioprostaglandins and thiosubstituted prostaglandin derivatives. These compounds are designed to serve as intraocular pressure-reducing agents. His inventions include pharmaceutical compositions that utilize these compounds and methods of treatment that effectively lower intraocular pressure. One notable method involves the combination of a prostaglandin with an adrenergic blocking agent, providing a novel approach to treating ocular hypertension or glaucoma. This method entails applying a mixture of these agents in an ophthalmically compatible carrier to achieve the desired therapeutic effect.
Career Highlights
Laszlo Z Bito has had a distinguished career, contributing to advancements in pharmaceutical sciences. He has worked with reputable institutions, including Columbia University and Kabi Pharmacia Ab, where he has furthered his research and development efforts in ocular therapeutics.
Collaborations
Throughout his career, Bito has collaborated with notable professionals in the field, including Johan W Stjernschantz and Bahram Resul. These collaborations have enriched his research and contributed to the development of innovative solutions for ocular health.
Conclusion
Laszlo Z Bito's work in the field of ocular therapeutics exemplifies his commitment to innovation and improving patient outcomes. His patents and collaborations reflect a dedication to advancing medical science, particularly in the treatment of ocular conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
